SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,179,000 | +139.4% | 71,133 | +39.8% | 3.74% | +120.4% |
| Q3 2019 | $3,834,000 | -48.9% | 50,898 | +3.0% | 1.70% | -42.6% |
| Q2 2019 | $7,507,000 | +24.1% | 49,403 | -2.6% | 2.96% | +42.5% |
| Q1 2019 | $6,047,000 | +9.1% | 50,735 | -0.1% | 2.07% | +18.9% |
| Q4 2018 | $5,545,000 | -35.5% | 50,810 | -4.5% | 1.74% | -27.7% |
| Q3 2018 | $8,596,000 | +13.3% | 53,223 | -7.3% | 2.41% | -4.1% |
| Q2 2018 | $7,588,000 | +21.6% | 57,409 | -31.8% | 2.51% | -17.9% |
| Q1 2018 | $6,238,000 | +30.3% | 84,191 | -2.2% | 3.06% | +48.6% |
| Q4 2017 | $4,788,000 | – | 86,047 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |